about
Myotoxic phospholipases A(2) isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells.Crotalus durissus collilineatus venom gland transcriptome: analysis of gene expression profile.Snake venom L-amino acid oxidases: an overview on their antitumor effects.Purification procedure for the isolation of a P-I metalloprotease and an acidic phospholipase A2 from Bothrops atrox snake venom.Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines.Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential.CR-LAAO, an L-amino acid oxidase from Calloselasma rhodostoma venom, as a potential tool for developing novel immunotherapeutic strategies against cancer.Molecular cloning and biochemical characterization of a myotoxin inhibitor from Bothrops alternatus snake plasma.Biochemical characterization and comparative analysis of two distinct serine proteases from Bothrops pirajai snake venom.Genotoxic effect of Bothrops snake venoms and isolated toxins on human lymphocyte DNA.Proteomic analysis of Bothrops pirajai snake venom and characterization of BpirMP, a new P-I metalloproteinase.Inhibition of snake venoms and phospholipases A(2) by extracts from native and genetically modified Eclipta alba: isolation of active coumestans.A new acidic myotoxic, anti-platelet and prostaglandin I2 inductor phospholipase A2 isolated from Bothrops moojeni snake venom.Evaluating the microbicidal, antiparasitic and antitumor effects of CR-LAAO from Calloselasma rhodostoma venom.An overview of the immune modulating effects of enzymatic toxins from snake venoms.Investigating possible biological targets of Bj-CRP, the first cysteine-rich secretory protein (CRISP) isolated from Bothrops jararaca snake venom.Antithrombotic activity of Batroxase, a metalloprotease from Bothrops atrox venom, in a model of venous thrombosis.rBaltMIP, a recombinant alpha-type myotoxin inhibitor from Bothrops alternatus (Rhinocerophis alternatus) snake, as a potential candidate to complement the antivenom therapy.Effects of Bothrops atrox venom and two isolated toxins on the human complement system: Modulation of pathways and generation of anaphylatoxins.Evaluation of the in vivo thrombolytic activity of a metalloprotease from Bothrops atrox venom using a model of venous thrombosis.Anticoagulant and fibrinogenolytic properties of the venom of Polybia occidentalis social wasp.Evaluation of the local inflammatory events induced by BpirMP, a metalloproteinase from Bothrops pirajai venom.Evaluation of the genotoxicity of Crotalus durissus terrificus snake venom and its isolated toxins on human lymphocytesCytotoxic and inflammatory potential of a phospholipase A2 from Bothrops jararaca snake venomHeterologous expression and biochemical and functional characterization of a recombinant alpha-type myotoxin inhibitor from Bothrops alternatus snakeImmune cells and mediators involved in the inflammatory responses induced by a P-I metalloprotease and a phospholipase A 2 from Bothrops atrox venomEffects of two serine proteases from Bothrops pirajai snake venom on the complement system and the inflammatory responseNew Insights on Moojase, a Thrombin-Like Serine Protease from Snake VenomInflammatory mediators involved in the paw edema and hyperalgesia induced by Batroxase, a metalloproteinase isolated from Bothrops atrox snake venom
P50
Q33349288-C052235B-6C73-45A6-96A0-7D1CFBB32F61Q33410940-11243614-29C0-4C1C-8598-A65D6E7B4E29Q33768212-E665F886-9FA6-420E-B59F-43108ECB7DCFQ35951250-B69477A1-E80F-459E-86BA-29976217D1FBQ36246909-6491A618-3182-4BF4-8E28-061944774C8FQ36800468-753CA2E5-E0D1-47D6-AD3F-10409D52E5CEQ37644405-E78A1496-5480-4214-8649-25B88128FA18Q39622109-C3BFADCC-4A6D-4410-9EDB-305D34920F6EQ44061808-3D21A188-A7B5-4694-BC6B-8ADF1199A890Q44655949-69BBB461-C176-4BC4-8897-3CD557E84D0AQ45028221-A7A98313-7B21-42D3-9FF3-F53FC21FCFB4Q46075212-06F49D52-11F4-4DA1-AABA-8FB3289AB43FQ46311197-9000AF2E-51D4-45A8-84FF-AC8B751079ADQ46702508-31B3D553-C1DA-4A38-9838-0F2BB03386EAQ47258535-B990D818-C2C9-4BB7-B9DD-967EBAA96506Q48534094-CEC34D16-F845-40A8-934D-935287C43373Q51051092-D814C524-F640-43ED-8807-1BCDA33A0206Q51091278-583B0442-F1F0-4B50-BEB7-B1CD930B6A0FQ51326256-30F05DC0-7122-4D0E-AF84-9ECD722D664EQ52146948-C95E8244-84AE-4155-8927-76C7356DF62CQ52707923-2435182D-0215-4092-BE97-FD0BD4256302Q53311093-431097EF-CC73-464B-BF97-0316C969DF68Q56787048-FAC6BCA8-76DC-40FA-962E-11D0CA01461DQ59327039-AC96B3FD-FC97-4CB4-8C16-154F6E97FB28Q60199534-398E9CF2-6FE2-430E-8EB8-135E0E9D9307Q60482314-75B092C0-3111-4396-877E-E160F0365F67Q60482334-26A7F7C6-A542-4C7E-978F-BB96B758BBDDQ60933793-624125B2-334A-43C4-B56C-4E12D8F052CBQ85373729-464E7194-F560-4656-8C59-562446EEA3DF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Danilo L. Menaldo
@ast
Danilo L. Menaldo
@en
Danilo L. Menaldo
@es
Danilo L. Menaldo
@nl
Danilo L. Menaldo
@sl
type
label
Danilo L. Menaldo
@ast
Danilo L. Menaldo
@en
Danilo L. Menaldo
@es
Danilo L. Menaldo
@nl
Danilo L. Menaldo
@sl
prefLabel
Danilo L. Menaldo
@ast
Danilo L. Menaldo
@en
Danilo L. Menaldo
@es
Danilo L. Menaldo
@nl
Danilo L. Menaldo
@sl
P106
P1153
16245683900
P21
P31
P496
0000-0002-8133-3266